Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The FDA gave accelerated approval to sonrotoclax, called Beqalzi TM, on May 13, 2026. It is approved for adults with mantle cell lymphoma that has come back or not responded after two treatments, including a BTK inhibitors (1)
There is no EMA EPAR or EU marketing approval for sonrotoclax as of May 2026
(1) [fda-grants-accelerated-approval-sonrotoclax-relapsed-or-refractory-mantle-cell-lymphoma](https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-sonro…